Teleflex Inc. (NYSE:TFX) – Equities research analysts at Leerink Swann dropped their Q3 2016 EPS estimates for shares of Teleflex in a report issued on Tuesday. Leerink Swann analyst R. Newitter now forecasts that the brokerage will post earnings of $1.79 per share for the quarter, down from their prior forecast of $1.80. Leerink Swann has a “Market Perform” rating and a $190.00 price objective on the stock. Leerink Swann also issued estimates for Teleflex’s FY2018 earnings at $8.75 EPS.
Teleflex (NYSE:TFX) last released its earnings results on Thursday, July 28th. The medical technology company reported $1.89 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.15. The firm earned $473.60 million during the quarter, compared to analyst estimates of $468.40 million. Teleflex had a return on equity of 15.59% and a net margin of 14.89%. The business’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.42 earnings per share.
Other equities analysts have also issued reports about the company. Barclays PLC restated an “overweight” rating and set a $183.00 target price (up from $170.00) on shares of Teleflex in a report on Tuesday, June 14th. Jefferies Group raised their target price on Teleflex from $157.00 to $185.00 and gave the company a “hold” rating in a report on Friday, July 29th. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $192.00 target price on the stock in a report on Wednesday, June 29th. Finally, Raymond James Financial Inc. raised Teleflex from an “outperform” rating to a “strong-buy” rating in a research report on Wednesday, June 1st. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $171.33.
Teleflex (NYSE:TFX) opened at 168.02 on Wednesday. The company has a 50-day moving average price of $179.77 and a 200 day moving average price of $169.38. The firm has a market capitalization of $7.40 billion, a price-to-earnings ratio of 29.82 and a beta of 0.83. Teleflex has a 1-year low of $122.14 and a 1-year high of $188.79.
The company also recently announced a quarterly dividend, which was paid on Thursday, September 15th. Investors of record on Monday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date of this dividend was Thursday, August 11th. Teleflex’s dividend payout ratio (DPR) is presently 24.11%.
A number of large investors have recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC purchased a new stake in Teleflex during the second quarter worth $118,000. Huntington National Bank increased its stake in Teleflex by 6.5% in the second quarter. Huntington National Bank now owns 820 shares of the medical technology company’s stock worth $145,000 after buying an additional 50 shares during the last quarter. Checchi Capital Advisers LLC increased its stake in Teleflex by 0.8% in the second quarter. Checchi Capital Advisers LLC now owns 837 shares of the medical technology company’s stock worth $148,000 after buying an additional 7 shares during the last quarter. Welch & Forbes LLC bought a new stake in Teleflex during the second quarter worth $204,000. Finally, Broderick Brian C bought a new stake in Teleflex during the second quarter worth $207,000. 93.77% of the stock is currently owned by institutional investors and hedge funds.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.
Receive News & Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.